JPMorgan Chase & Co. Trims Braskem (NYSE:BAK) Target Price to $9.50

Braskem (NYSE:BAKFree Report) had its target price trimmed by JPMorgan Chase & Co. from $10.00 to $9.50 in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.

Separately, Citigroup upgraded shares of Braskem from a neutral rating to a buy rating in a report on Tuesday, August 20th.

View Our Latest Report on Braskem

Braskem Stock Performance

BAK opened at $6.41 on Tuesday. The business’s 50-day moving average price is $6.42 and its two-hundred day moving average price is $7.57. Braskem has a 1 year low of $5.28 and a 1 year high of $10.98. The company has a debt-to-equity ratio of 23.25, a current ratio of 1.31 and a quick ratio of 0.84.

Braskem (NYSE:BAKGet Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.30. The business had revenue of $3.66 billion for the quarter, compared to analyst estimates of $3.56 billion. Braskem had a negative return on equity of 276.59% and a negative net margin of 12.98%. On average, equities research analysts anticipate that Braskem will post -1.3 earnings per share for the current year.

Hedge Funds Weigh In On Braskem

Hedge funds have recently modified their holdings of the stock. Boston Partners acquired a new position in Braskem during the first quarter valued at approximately $627,000. Jump Financial LLC raised its stake in shares of Braskem by 4.3% during the 4th quarter. Jump Financial LLC now owns 67,392 shares of the company’s stock worth $594,000 after purchasing an additional 2,790 shares in the last quarter. Trexquant Investment LP boosted its holdings in shares of Braskem by 197.1% in the 4th quarter. Trexquant Investment LP now owns 141,852 shares of the company’s stock valued at $1,251,000 after buying an additional 94,099 shares during the last quarter. SPX Gestao de Recursos Ltda grew its stake in shares of Braskem by 266.9% in the fourth quarter. SPX Gestao de Recursos Ltda now owns 239,536 shares of the company’s stock valued at $2,113,000 after buying an additional 174,250 shares in the last quarter. Finally, Marshall Wace LLP increased its holdings in Braskem by 872.0% during the second quarter. Marshall Wace LLP now owns 268,352 shares of the company’s stock worth $1,731,000 after buying an additional 240,744 shares during the last quarter.

About Braskem

(Get Free Report)

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.

Read More

Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.